Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor

Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor

Most people with cystic fibrosis (CF) are diagnosed following abnormal newborn screening (NBS), which begins with measurement of immunoreactive trypsinogen (IRT) values. A case report found low concentrations of IRT in an infant with CF exposed to the CF transmembrane conductance regulator (CFTR) mo...

Full description

Bibliographic Details
Main Authors: Payal Patel, Jana Yeley, Cynthia Brown, Melissa Wesson, Barbara G. Lesko, James E. Slaven, James F. Chmiel, Raksha Jain, Don B. Sanders
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Neonatal Screening
Subjects:
cystic fibrosis
newborn screening
immunoreactive trypsinogen
Online Access:https://www.mdpi.com/2409-515X/9/1/10

Internet

https://www.mdpi.com/2409-515X/9/1/10

Similar Items